Skip to main content
Back
Watch Compare

Actinium Pharmaceuticals, Inc.

Data quality: 100%
ATNM
NYSE Manufacturing Chemicals
$1.08
▼ $0.06 (-5.26%)
Mkt Cap: 34.67 M
Price
$1.11
Mkt Cap
34.67 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue declined -47.04% annually over 5 years
Negative free cash flow of -24.68 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 58.15%
Capital intensive — 115.56% of revenue goes to capex

Growth

Revenue Growth (5Y)
-47.04%
Below sector avg (1.82%)
Revenue (1Y)11.11%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-206.65%
Below sector avg (-53.47%)
ROIC-55.06%
Net Margin-37652.22%
Op. Margin-40274.44%

Safety

Debt / Equity
N/A
Current Ratio7.96
Interest CoverageN/A

Valuation

PE (TTM)
-1.02
Above sector avg (-1.48)
P/B Ratio2.52
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -1.0 -1.5
P/B 2.5 1.6
ROE % -206.7 -53.5
Net Margin % -37652.2 -41.5
Rev Growth 5Y % -47.0 1.8
D/E — 0.3

Analyst Price Target

5 analysts
Buy
Current
$1.08
+363.0%
Target
$5.00
$2.00
$5.00
$9.00
Forecast
Forward P/E -1.92
Forward EPS -$0.56
Est. Revenue 12.93 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.56
-$0.85 – -$0.03
 12.93 M 3
FY2026 -$0.89
-$1.09 – -$0.66
 0.0 3

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.19 -$0.19 -1.8%
Q32025 -$0.32 -$0.16 +50.5%
Q22025 -$0.35 -$0.22 +37.6%
Q12025 -$0.28 -$0.51 -83.8%

ETFs Holding This Stock

BRSIX BRSIX
0.12% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 11.11% Revenue Growth (3Y) 5.41%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -47.04% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 90,000.0 Net Income (TTM) -33.89 M
ROE -206.65% ROA -56.87%
Gross Margin N/A Operating Margin -40274.44%
Net Margin -37652.22% Free Cash Flow (TTM) -24.68 M
ROIC -55.06% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 7.96
Interest Coverage N/A Asset Turnover 0.00
Working Capital 47.53 M Tangible Book Value 13.78 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.02 Forward P/E N/A
P/B Ratio 2.52 P/S Ratio 385.22
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -71.20%
Market Cap 34.67 M Enterprise Value -18.72 M
Per Share
EPS (Diluted TTM) -1.09 Revenue / Share 0.00
FCF / Share -0.79 OCF / Share -0.78
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 115.56% FCF Conversion 72.84%
SBC-Adj. FCF -35.20 M Growth Momentum 58.15

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 90,000.0 81,000.0 81,000.0 1.03 M 1.14 M
Net Income -33.89 M -38.24 M -48.82 M -33.02 M -24.77 M
EPS (Diluted) -1.09 -1.27 -1.83 -1.37 —
Gross Profit — — — — —
Operating Income -36.25 M -42.12 M -51.92 M -34.10 M -24.96 M
EBITDA — — — — —
R&D Expenses 21.12 M 30.05 M 38.67 M 23.14 M 18.03 M
SG&A Expenses — — — — —
D&A 173,000.0 197,000.0 790,000.0 699,000.0 524,000.0
Interest Expense — — 3.10 M 1.09 M 190,000.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 51.78 M 76.90 M 81.45 M 114.19 M 80.39 M
Total Liabilities 43.94 M 44.14 M 45.07 M 47.71 M 6.84 M
Shareholders' Equity 7.83 M 32.76 M 36.38 M 66.48 M 73.55 M
Total Debt — — — — —
Cash & Equivalents 48.00 M 72.90 M 76.68 M 108.91 M 77.83 M
Current Assets 49.38 M 74.51 M 78.26 M 110.94 M 79.75 M
Current Liabilities 7.97 M 8.15 M 8.49 M 10.63 M 6.84 M